Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Semax

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 80714-61-0, Acth (4-7), pro-gly-pro-, Mehfpgp, Met-glu-his-phe-pro-gly-pro, I5fal2585h, Acth (4-7), prolyl-glycyl-proline-
    Molecular Formula
    C37H51N9O10S
    Molecular Weight
    813.9  g/mol
    InChI Key
    AFEHBIGDWIGTEH-AQRCPPRCSA-N
    FDA UNII
    I5FAL2585H
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid
    2.1.2 InChI
    InChI=1S/C37H51N9O10S/c1-57-16-13-24(38)32(50)42-25(11-12-31(48)49)33(51)43-26(18-23-19-39-21-41-23)34(52)44-27(17-22-7-3-2-4-8-22)36(54)46-15-5-9-28(46)35(53)40-20-30(47)45-14-6-10-29(45)37(55)56/h2-4,7-8,19,21,24-29H,5-6,9-18,20,38H2,1H3,(H,39,41)(H,40,53)(H,42,50)(H,43,51)(H,44,52)(H,48,49)(H,55,56)/t24-,25-,26-,27-,28-,29-/m0/s1
    2.1.3 InChI Key
    AFEHBIGDWIGTEH-AQRCPPRCSA-N
    2.2 Other Identifiers
    2.2.1 UNII
    I5FAL2585H
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Acth (4-7), Pro-gly-pro-

    2. Acth (4-7), Prolyl-glycyl-proline-

    3. Pro-gly-pro-acth (4-7)

    2.3.2 Depositor-Supplied Synonyms

    1. 80714-61-0

    2. Acth (4-7), Pro-gly-pro-

    3. Mehfpgp

    4. Met-glu-his-phe-pro-gly-pro

    5. I5fal2585h

    6. Acth (4-7), Prolyl-glycyl-proline-

    7. Pro-gly-pro-acth (4-7)

    8. Unii-i5fal2585h

    9. L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-l-proline

    10. (2s)-1-[2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic Acid

    11. L-proline, 1-(n-(1-(n-(n-(n-l-methionyl-l-alpha-glutamyl)-l-histidyl)-l-phenylalanyl)-l-prolyl)glycyl)-

    12. Semax?

    13. H-met-glu-his-phe-pro-gly-pro-oh

    14. Schembl7200319

    15. Glxc-25922

    16. Hy-p1146

    17. Akos040744795

    18. At42448

    19. Da-77788

    20. Met-glu-his-phe-pro-gly-pro [who-dd]

    21. Cs-0028296

    22. Methionyl-glutamyl-histidyl-phenylalanyl-prolyl-glycyl-proline

    23. L-proline, L-methionyl-l-.alpha.-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-

    24. L-proline, L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 813.9 g/mol
    Molecular Formula C37H51N9O10S
    XLogP3-2.8
    Hydrogen Bond Donor Count8
    Hydrogen Bond Acceptor Count13
    Rotatable Bond Count21
    Exact Mass Da
    Monoisotopic Mass Da
    Topological Polar Surface Area312
    Heavy Atom Count57
    Formal Charge0
    Complexity1450
    Isotope Atom Count0
    Defined Atom Stereocenter Count6
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Enzyme Inhibitors

    Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

    Neuroprotective Agents

    Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)

    Nootropic Agents

    Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)